Guidelines on the use of extracorporeal photopheresis

BACKGROUND: After the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma was published in 1983 with its subsequent recognition by the FDA for its refractory forms, the technology has shown significant promise in the treatment of othe...

Descripción completa

Detalles Bibliográficos
Autores principales: Knobler, R, Berlin, G, Calzavara-Pinton, P, Greinix, H, Jaksch, P, Laroche, L, Ludvigsson, J, Quaglino, P, Reinisch, W, Scarisbrick, J, Schwarz, T, Wolf, P, Arenberger, P, Assaf, C, Bagot, M, Barr, M, Bohbot, A, Bruckner-Tuderman, L, Dreno, B, Enk, A, French, L, Gniadecki, R, Gollnick, H, Hertl, M, Jantschitsch, C, Jung, A, Just, U, Klemke, C-D, Lippert, U, Luger, T, Papadavid, E, Pehamberger, H, Ranki, A, Stadler, R, Sterry, W, Wolf, IH, Worm, M, Zic, J, Zouboulis, CC, Hillen, U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Guidelines on the Use of Extracorporeal Photopheresis. Publication of This Supplement was Supported by a Grant From the European Dermatology Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291097/
https://www.ncbi.nlm.nih.gov/pubmed/24354653
http://dx.doi.org/10.1111/jdv.12311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291097/
https://www.ncbi.nlm.nih.gov/pubmed/24354653
http://dx.doi.org/10.1111/jdv.12311

Ejemplares similares